Hansard Adam (CIK 0001805556)

Latest company ownership

Role: Chief Commercial Officer
Shares held
732,919
Last filed at
Mar 18, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 14, 2024 Mar 18, 2024 Applied Therapeutics, Inc. Chief Commercial Officer Sell 40.0 -48,871 -6.25% $263.4K
Nov 30, 2023 Dec 1, 2023 Applied Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -965 -0.25% $1.9K
Sep 27, 2023 Sep 29, 2023 Applied Therapeutics, Inc. Chief Commercial Officer Sell 46.3 -9,720 -2.48% $26.2K
Jan 11, 2023 Jan 13, 2023 Applied Therapeutics, Inc. Chief Commercial Officer Sell 90.0 +295,505 304.74% $4.1K
May 26, 2021 May 28, 2021 Applied Therapeutics, Inc. Chief Commercial Officer Sell 42.5 -2,894 -7.94% $53.1K